×
About 33,913 results

ALLMedicine™ Renal Failure Center

Research & Reviews  10,392 results

Neonates with acute liver failure have higher overall mortality but similar post-transp...
https://doi.org/10.1002/lt.26537
Liver Transplantation : Official Publication of the Ameri... Antala S, Whitehead B et. al.

Jun 26th, 2022 - Neonatal acute liver failure (ALF) carries a high mortality rate, however, little data exist on its peri-transplant hospital course. This project aimed to identify factors associated with outcomes in neonates with ALF using large multi-center data...

Dedifferentiated liposarcoma (DDLPS) in the rectum: A case report.
https://doi.org/10.1177/03000605221102081
The Journal of International Medical Research; Li W, Liu Q et. al.

Jun 26th, 2022 - Dedifferentiated liposarcoma (DDLPS) is a rare subtype of liposarcoma with a poor prognosis. This current case report describes a rectal DDLPS in a 68-year-old Chinese male that presented with lower abdominal pain and weight loss. Computed tomogra...

Management of osteoporosis in patients with chronic kidney disease.
https://doi.org/10.1007/s00198-022-06462-3 10.1016/0002-9343(93)90218-E 10.1001/jama.285.6.785 10.1007/s00198-021-05975-7 10.1093/ndt/gfaa192 10.1681/ASN.2010121253 10.1038/sj.ki.5001754 10.1038/kisup.2013.93 10.1007/s40620-017-0406-x 10.1007/s00198-014-2970-4 10.4103/1319-2442.206439 10.3109/0886022X.2013.815102 10.1186/1471-2474-10-60 10.1002/jbm4.10067 10.1038/sj.ki.5000311 10.1681/ASN.2009121208 10.1002/jbmr.309 10.1001/archinte.167.2.133 10.1681/ASN.2006050546 10.1016/S0272-6386(04)00958-8 10.2106/00004623-199508000-00019 10.1111/nep.13457 10.1093/ndt/14.8.1922 10.1146/annurev-physiol-021119-034650 10.2337/diaspect.21.1.19 10.1172/JCI118224 10.1046/j.1523-1755.2001.00027.x 10.1038/ki.2015.156 10.1007/s001090100226 10.5414/CN109650 10.1002/jbmr.1644 10.2215/CJN.12871211 10.1159/000515534 10.1007/s00198-018-4704-5 10.1016/j.afos.2019.12.002 10.1002/jbmr.556 10.1016/S0002-9629(15)40516-6 10.1007/s00198-013-2524-1 10.2215/CJN.06040614 10.1016/j.kint.2018.09.022 10.1007/s00198-020-05458-1 10.1007/s00198-018-4468-y 10.2215/CJN.00720116 10.1016/j.bone.2018.08.006 10.1007/s00198-012-2155-y 10.1016/j.bone.2014.06.034 10.1007/s00198-014-2761-y 10.1002/jbmr.2734 10.1007/s00223-013-9722-x 10.1007/s00198-020-05804-3 10.1385/JCD:3:3:281 10.1007/s00198-014-2794-2 10.1385/JCD:8:3:362 10.1007/s00198-016-3532-8 10.1007/s11914-009-0017-0 10.1007/s00198-010-1501-1 10.1007/s11914-005-0018-6 10.1007/s00198-017-4082-4 10.1053/j.ajkd.2015.06.023 10.1046/j.1523-1755.2001.00949.x 10.1681/ASN.V73506 10.1111/nep.13593 10.1038/sj.ki.5002769 10.1002/jbmr.3471 10.1186/s12882-017-0692-5 10.1681/ASN.2010121275 10.1093/ndt/gfu055 10.1093/ndt/gfr317 10.1016/j.kint.2015.12.004 10.1007/s00198-004-1805-0 10.1016/j.rcl.2010.02.013 10.1063/1.3693085 10.1002/jbmr.1731 10.3389/fendo.2020.00015 10.1016/j.bone.2020.115241 10.1111/j.1523-1755.2005.00603.x 10.1186/s12882-020-01999-z 10.1007/s00223-019-00606-0 10.1111/j.1440-1797.2010.01412.x 10.1093/ndt/gfq725 10.1097/01.ASN.0000129337.50739.48 10.1038/ki.2014.349 10.1016/j.kint.2018.12.015 10.1007/s00223-021-00844-1 10.1210/clinem/dgaa851 10.1002/jbmr.403 10.1007/s10067-016-3447-y 10.1210/jc.2014-1154 10.1210/jc.2015-1259 10.1007/s00198-018-4533-6 10.1038/s41598-020-59143-8 10.1002/jbmr.3676 10.1093/ndt/gfaa359 10.1155/2017/6218129 10.1053/j.ajkd.2015.03.012 10.1002/jbmr.1613 10.1007/s40620-016-0334-1 10.1007/s11657-019-0587-0 10.1002/jbmr.3337 10.2169/internalmedicine.54.4946 10.1053/j.ajkd.2009.12.039 10.1159/000341864 10.1359/JBMR.050817 10.1359/jbmr.070112 10.1186/s12882-017-0478-9 10.1002/jbmr.2361 10.1159/000276666 10.1016/j.kint.2017.04.006 10.1016/j.kisu.2017.04.001 10.1046/j.1523-1755.2003.00005.x 10.1111/j.1744-9987.2011.00929.x 10.3109/13697137.2013.830605 10.1111/1744-9987.12867 10.1053/j.ajkd.2015.01.025 10.1007/s00198-015-3377-6 10.1159/000316708 10.1007/s00198-006-0189-8 10.1080/03007995.2019.1656955 10.1007/s00774-021-01253-y 10.1093/ndt/gfy129 10.1161/ATVBAHA.119.312371 10.1002/jbmr.4283 10.1016/j.kint.2021.04.043 10.1161/CIRCULATIONAHA.121.053708 10.1002/jbmr.2043 10.1097/00029330-200807020-00007 10.1038/ki.2015.315 10.7326/M16-2752 10.1007/s11914-018-0483-3 10.1016/j.kint.2021.09.011 10.1136/annrheumdis-2020-eular.4539 10.1001/jamainternmed.2020.6615 10.1001/jama.2021.11330 10.1111/sdi.12833 10.1097/01.tp.0000203557.36884.e3 10.1016/j.bone.2020.115554 10.1097/TP.0b013e3181a6bbda 10.1016/j.transproceed.2018.04.032 10.1007/s00198-019-04906-x 10.1681/ASN.2011060623 10.1681/ASN.2018060656 10.1093/ndt/gfaa371 10.1097/TP.0000000000001547 10.1111/j.1600-6143.2008.02327.x
Osteoporosis International : a Journal Established as Res... Abdalbary M, Sobh M et. al.

Jun 25th, 2022 - Patients with CKD have a 4-fivefold higher rate of fractures. The incidence of fractures increases with deterioration of kidney function. The process of skeletal changes in CKD patients is characterized by compromised bone strength because of dete...

Problem in the Recent American Heart Association Guideline on Secondary Stroke Preventi...
https://doi.org/10.1161/STROKEAHA.122.038640
Stroke Spence JD, Hankey GJ

Jun 25th, 2022 - In this article, we discuss a problem in the most recent American Heart Association guideline on secondary stroke prevention that apparently arose from the rules of evidence imposed on the guideline panel. We are told by the cochair of the panel t...

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04933539

Jun 24th, 2022 - Background: Smoldering multiple myeloma (SMM) is a precursor condition to MM defined by the clinical parameters of M-protein >=3.0 g/dL or bone marrow plasma cells >=10%, and absence of end organ disease. Patients with high-risk SMM have a risk of...

see more →

Guidelines  13 results

ACR Appropriateness Criteria® Renal Failure.
https://doi.org/10.1016/j.jacr.2021.02.019
Journal of the American College of Radiology : JACR; , Wong-You-Cheong JJ et. al.

May 8th, 2021 - Renal failure can be divided into acute kidney injury and chronic kidney disease. Both are common and result in increased patient morbidity and mortality. The etiology is multifactorial and differentiation of acute kidney injury from chronic kidne...

Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aort...
https://doi.org/10.1016/j.jvs.2020.05.076
Journal of Vascular Surgery; Upchurch GR, Escobar GA et. al.

Jul 7th, 2020 - Thoracic aortic diseases, including disease of the descending thoracic aorta (DTA), are significant causes of death in the United States. Open repair of the DTA is a physiologically impactful operation with relatively high rates of mortality, para...

ACR Appropriateness Criteria® Radiologic Management of Urinary Tract Obstruction.
https://doi.org/10.1016/j.jacr.2020.01.039
Journal of the American College of Radiology : JACR; , Scheidt MJ et. al.

May 7th, 2020 - Acute obstructive uropathy is a medical emergency, which often is accompanied by acute renal failure or sepsis. Treatment options to resolve the acute obstructive process include conservative medical management, retrograde ureteral stenting, or pl...

Management of adults with diabetes on the haemodialysis unit: summary of guidance from ...
https://doi.org/10.1111/dme.13676
Diabetic Medicine : a Journal of the British Diabetic Ass... Frankel AH, Kazempour-Ardebili S et. al.

Aug 29th, 2018 - Diabetic nephropathy remains the principal cause of end-stage renal failure in the UK and its prevalence is set to increase. People with diabetes and end-stage renal failure on maintenance haemodialysis are highly vulnerable, with complex comorbid...

Practice Bulletin No. 183 Summary: Postpartum Hemorrhage.
https://doi.org/10.1097/AOG.0000000000002346
Obstetrics and Gynecology;

Sep 25th, 2017 - Maternal hemorrhage, defined as a cumulative blood loss of greater than or equal to 1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after the birth process, remains the leading cause of maternal mortality wor...

see more →

Drugs  480 results see all →

Clinicaltrials.gov  1,512 results

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04933539

Jun 24th, 2022 - Background: Smoldering multiple myeloma (SMM) is a precursor condition to MM defined by the clinical parameters of M-protein >=3.0 g/dL or bone marrow plasma cells >=10%, and absence of end organ disease. Patients with high-risk SMM have a risk of...

Search for New Methods to Detect Acute Renal Failure
https://clinicaltrials.gov/ct2/show/NCT00026702

Jun 24th, 2022 - The mortality of acute renal failure (ARF) remains high despite advances in supportive care. There are no established effective drug therapies, and dialysis may promote renal injury via hypotension or neutrophil activation. Many agents [e.g., mann...

Clinical and Laboratory Study of Methylmalonic Acidemia
https://clinicaltrials.gov/ct2/show/NCT00078078

Jun 24th, 2022 - Methylmalonic acidemia (MMA), one of the most common inborn errors of organic acid metabolism, is heterogeneous in etiology and clinical manifestations. Affected patients with cblA, cblB and mut classes of MMA are medically fragile and can suffer ...

In Vitro Immunomodulation in Membranous Nephropathy Relapses
https://clinicaltrials.gov/ct2/show/NCT05428605

Jun 23rd, 2022 - Membranous Nephropathy (MN) is a rare autoimmune renal disease and the first cause of nephrotic syndrome in adults. In one third of cases, it progresses to end-stage renal failure. Rituximab has shown very good efficacy (60-80%) and excellent safe...

Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients With Cardio Renal Syndrome With Severe Renal Impairment
https://clinicaltrials.gov/ct2/show/NCT05428631

Jun 23rd, 2022 - There are currently 1.5 million heart failure patients in France. The high morbidity and mortality make it a major public health issue. Renal failure, present in 40% of these patients, is one of the main comorbidities of heart failure and makes it...

see more →

News  1,165 results

High Maternal, Fetal Morbidity Rates in SLE Pregnancies
https://www.medscape.com/viewarticle/974934

Jun 2nd, 2022 - COPENHAGEN — Pregnant women with systemic lupus erythematosus (SLE) are at significantly higher risk of requiring transfusion, developing a cerebrovascular disorder, or developing acute renal failure than pregnant women without SLE, a review of da...

Retiform Purpura on the Legs
https://www.mdedge.com/dermatology/article/254484/dermatopathology/retiform-purpura-legs
Mark C. Marchitto, MD, Liesl Grenier, MD et. al.

May 10th, 2022 - The Diagnosis: Calciphylaxis Histopathology revealed epidermal and dermal necrosis, a perivascular neutrophilic infiltrate, and scattered microcalcifications within small- and medium-sized subcutaneous vessels, consistent with a diagnosis of calci.

Dr. Larocca on Recent Advancements in R/R Multiple Myeloma
https://www.onclive.com/view/dr-larocca-on-recent-advancements-in-r-r-multiple-myeloma

Apr 20th, 2022 - Alessandra Larocca, MD, PhD, hematologist, Division of Hematology, University of Torino, Azienda Ospedaliero‐Universitaria Città della Salute e della Scienza di Torino, Italy, discusses recent advancements in relapsed/refractory multiple myeloma. ...

Gene Testing for Kidney Disease Risk Prompts Behavior Change
https://www.medscape.com/viewarticle/969945

Mar 9th, 2022 - Giving patients and their providers genetic test results for kidney failure risk promotes positive behavioral change that could decrease an individual's likelihood of developing chronic kidney disease (CKD) and end-stage renal failure (ESRF), a ne...

BLA for Vicineum in High-Risk, BCG-Unresponsive NMIBC Remains on Track for Regulatory Decision
https://www.onclive.com/view/bla-for-vicineum-in-high-risk-bcg-unresponsive-nmibc-remains-on-track-for-regulatory-decision

Mar 1st, 2022 - The late-stage clinical company Sesen Bio recently participated in a Late-Cycle Meeting with the FDA to discuss the biologics license application (BLA) for Vicineum as a potential option for patients with Bacillus Calmette-Guérin (BCG)–unresponsiv...

see more →

Patient Education  3 results see all →